IBM announced the availability of Windows Compute Cluster Server 2003 for the IBM System Cluster 1350 to enable mid-market and enterprise clients to take advantage of high-performance cluster computing.
Pall Corp.’s Omega T- Series Membrane Cassettes are constructed with high-performance materials that reduce extractables to deliver high-purity biological solutions.
Affymax Inc. plans to initiate phase III clinical studies with Hematide in chronic renal failure patients following recent discussions with the FDA on the design of the clinical trial program.
EpiCept Corp. will study EpiCept NP-1 for the treatment of chemotherapy-induced peripheral neuropathy (CPN).
The World Health Organization (WHO) expanded its clinical trial registry platform to include trial registers from China and India.
A patch that delivers Novartis’ Exelon, an Alzheimer’s disease medication, through the patient’s skin has been recommended for approval in the European Union.
Ring Out the Old.....
Start-up life sciences companies have an alternative to dwindling venture capital by seeking small business grants from federal granting agencies. The money is available for riskier studies, but the requirements are no less strict than those of private investors.
Companies looking to license new technologies and academics seeking to commercialize their research have different goals and viewpoints. Getting them to reach an agreement can be complicated. G&P Editors Sean Keating, Tanuja Koppal, and Bill Schu recently spoke with a panel of experts on technology transfer a
BioTek Instruments’ new microplate instrumentation technology includes the Synergy 4 multi-detection microplate reader with a multi-mode reader that combines filter-based and quadruple monochromator-based fluorescence detection technology in one instrument.
While venture capital funding remains strong for biotechnology companies, most money tends to go to later rounds with lesser risk. Scientific advancements and creative funding sources are helping biotech entrepreneurs get their ventures off the ground. The first working draft of the human genome was completed in 2
Strata SPE sorbents are available from Phenomenex, Inc. in a 20x2.0mm cartridge for on-line processing and multiple advantages.
Investment capital and proximity to talent are key ingredients to raise a herd of world-class biotechs. In the race for the next biotech hub, developed countries don’t always have all the advantages.
Roche Applied Science released a new Rapid DNA Dephos and Ligation Kit that provides dephosphorylation and ligation of sticky- or blunt-end DNA fragments.